Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Natus Medical Inc Reaffirms Q2 2013 Guidance; Reaffirms FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance


Monday, 20 May 2013 07:00am EDT 

Natus Medical Inc reaffirmed second quarter 2013 guidance and expects revenue in the range of $86 million to $90 million and non-GAAP earnings per share (EPS) in the range of $0.17-$0.20. For fiscal 2013 the Company expects to report revenue of $362 million to $367 million and non-GAAP earnings per share of $0.85 to $0.88. The Company most recently reported that it expected to report non-GAAP earnings per share of $0.84 to $0.87. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $89 million and EPS of $0.19 for second quarter of 2013; revenue of $364 million and EPS of $0.84 for fiscal 2013. 

Company Quote

34.44
-0.25 -0.72%
3:27pm EST